Patent Number: 6,168,804

Title: Method for eliciting Th1-specific immune response

Abstract: A method is provided for treating a Th1 mediated disease state by administration to a subject of a slow release vehicle such as a liposome or microsphere formulation containing an antigenic peptide and a Th1 specific immunomodulator wherein the antigenic peptide contains a T cell epitope and is released from the vehicle at a rate in the range from about 10 to 2 weight percent of the peptide in 24 hours at C.

Inventors: Samuel; John (Edmonton, CA), Kwon; Glen (Waunakee, WI)

Assignee: University of Alberta

International Classification: A61K 39/29 (20060101); A61K 9/127 (20060101); A61K 9/16 (20060101); A61K 39/00 (20060101); C07K 14/435 (20060101); C07K 14/705 (20060101); A61K 009/127 (); A61K 039/00 (); A61K 045/00 (); A61K 047/44 ()

Expiration Date: 01/02/2018